For help on how to get the results you want, see our search tips.
15 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Exceptional circumstances Remove Exceptional circumstances filter
Additional monitoring Remove Additional monitoring filter
Application type
Post-authorisation Remove Post-authorisation filter
-
List item
Summary of opinion: Jorveza
budesonide, opinion date: 26/03/2020, Positive, Last updated: 27/03/2020 -
List item
Summary of opinion: Adcetris
brentuximab vedotin, opinion date: 26/03/2020, Positive, Last updated: 27/03/2020 -
List item
Summary of opinion: Emgality
galcanezumab, opinion date: 27/02/2020, Negative, Last updated: 28/02/2020 -
List item
Summary of opinion: Darzalex
daratumumab, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Ultomiris
ravulizumab, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Alunbrig
brigatinib, opinion date: 27/02/2020, Positive, Last updated: 28/02/2020 -
List item
Summary of opinion: Braftovi
encorafenib, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Cablivi
caplacizumab, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Ofev
nintedanib, opinion date: 27/02/2020, Positive, Last updated: 28/02/2020 -
List item
Summary of opinion: Taltz
ixekizumab, opinion date: 28/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Sovaldi
sofosbuvir, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Harvoni
ledispavir / sofosbuvir, opinion date: 30/04/2020, Positive, Last updated: 30/04/2020 -
List item
Summary of opinion: Ofev
nintedanib, opinion date: 28/05/2020, Positive, Last updated: 29/05/2020 -
List item
Summary of opinion: Taltz
ixekizumab, opinion date: 28/05/2020, Positive, Last updated: 29/05/2020